rs138665095
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PP3_ModeratePP5
The NM_000755.5(CRAT):c.962G>A(p.Arg321His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,613,384 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R321C) has been classified as Uncertain significance.
Frequency
Consequence
NM_000755.5 missense
Scores
Clinical Significance
Conservation
Publications
- neurodegeneration with brain iron accumulation 8Inheritance: Unknown, AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CRAT | NM_000755.5 | c.962G>A | p.Arg321His | missense_variant | Exon 7 of 14 | ENST00000318080.7 | NP_000746.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152232Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000642 AC: 16AN: 249196 AF XY: 0.0000667 show subpopulations
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461034Hom.: 0 Cov.: 34 AF XY: 0.0000193 AC XY: 14AN XY: 726824 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152350Hom.: 0 Cov.: 34 AF XY: 0.0000268 AC XY: 2AN XY: 74496 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Neurodegeneration with brain iron accumulation 8 Pathogenic:2Uncertain:1
Observed as a homozygote. -
- -
This sequence variant is a single nucleotide substitution (G>A) at coding position 962 of the CRAT gene that results in an arginine to histidine amino acid change at residue 321 of the CRAT protein. This is a previously reported variant (ClinVar) that has been oberved in individuals with neurodegeneration with brain iron accumulation in the literature (PMID: 29395073, 34085946). This variant is observed in the gnomAD population dataset (17 alleles of 280566 or 0.006%). Bioinformatic tools predict that this variant would be damaging, and the Arg321 residue is highly conserved across the mammalian species examined. Functiol studies testing the effect of this variant suggest that it elimites protein expression and reduces the levels of very long chain fatty acids (PMID: 29395073). At this time there is insufficient evidence to determine if this variant is pathogenic or benign. Therefore, we consider this to be a variant of uncertain significance. ACMG Criteria: PM2, PP3, PS3 -
Neurodegeneration with brain iron accumulation Pathogenic:1
The homozygous c.962G>A variant (p.Arg321His) in CRAT is a rare SNP (rs138665095, ExAc: A=0.0042%) that has never been reported to be homozygous in the control population. It alters a highly conserved amino acid residue. The variant was absent from 110 NBIA subject and 200 control chromosomes. -
not provided Uncertain:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 321 of the CRAT protein (p.Arg321His). This variant is present in population databases (rs138665095, gnomAD 0.08%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with CRAT-related conditions (PMID: 29395073, 34085946). ClinVar contains an entry for this variant (Variation ID: 503495). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CRAT protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at